Geode Capital Management
AMRI

Geode Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Geode Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-212,835
Closed -$4.62M – 4109
2017
Q2 		$4.62M Buy
212,835
+8,354
+4% +$152K ﹤0.01% 2197
2017
Q1 		$2.87M Buy
204,481
+6,853
+3% +$112K ﹤0.01% 2450
2016
Q4 		$3.71M Buy
197,628
+6,542
+3% +$111K ﹤0.01% 2256
2016
Q3 		$3.15M Buy
191,086
+2,622
+1% +$38.8K ﹤0.01% 2265
2016
Q2 		$2.53M Buy
188,464
+2,726
+1% +$39.8K ﹤0.01% 2337
2016
Q1 		$2.84K Buy
185,738
+21,565
+13% +$338K ﹤0.01% 2219
2015
Q4 		$3.26M Buy
164,173
+1,381
+0.8% +$26.2K ﹤0.01% 2164
2015
Q3 		$2.83M Buy
162,792
+11,546
+8% +$235K ﹤0.01% 2208
2015
Q2 		$3.06M Buy
151,246
+15,220
+11% +$294K ﹤0.01% 2237
2015
Q1 		$2.39M Buy
136,026
+3,546
+3% +$60.4K ﹤0.01% 2331
2014
Q4 		$2.16M Buy
132,480
+16,758
+14% +$308K ﹤0.01% 2379
2014
Q3 		$2.55M Sell
115,722
-22,220
-16% -$455K ﹤0.01% 2207
2014
Q2 		$2.77M Sell
137,942
-8,668
-6% -$147K ﹤0.01% 2177
2014
Q1 		$2.72M Sell
146,610
-175,902
-55% -$2.42M ﹤0.01% 2159
2013
Q4 		$3.25M Buy
322,512
+164,086
+104% +$1.98M ﹤0.01% 2000
2013
Q3 		$2.04M Buy
158,426
+54,116
+52% +$666K ﹤0.01% 2157
2013
Q2 		$1.24M Buy
+104,310
New +$1.13M ﹤0.01% 2345

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Geode Capital Management's AMRI Position: Q3 2017 in Review

Geode Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 212,835 shares — an estimated $4.62M sold.

Geode Capital Management first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $4.62M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Geode Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Geode Capital Management sold 212,835 Albany Molecular Research Inc shares in Q3 2017, an estimated $4.62M.
  • Geode Capital Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Geode Capital Management's Albany Molecular Research Inc position peaked at $4.62M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Geode Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.